TSE:TRL

Trilogy International Partners Stock Forecast, Price & News

C$1.90
+0.02 (+1.06 %)
(As of 06/18/2021 12:00 AM ET)
Add
Compare
Today's Range
C$1.90
C$1.92
50-Day Range
C$1.59
C$2.00
52-Week Range
C$0.85
C$2.11
Volume10,675 shs
Average Volume34,433 shs
Market CapitalizationC$113.85 million
P/E RatioN/A
Dividend Yield1.43%
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive TRL News and Ratings via Email

Sign-up to receive the latest news and ratings for Trilogy International Partners and its competitors with MarketBeat's FREE daily newsletter.


Trilogy International Partners logo

About Trilogy International Partners

TIP Inc. is the parent of Trilogy International Partners LLC ("Trilogy LLC"), an international wireless and fixed broadband telecommunications operator formed by wireless industry veterans John Stanton, Theresa Gillespie and Brad Horwitz. Trilogy LLC's founders have successfully bought, built, launched and operated communications businesses in 15 international markets and the United States. Trilogy LLC, together with its consolidated subsidiaries in New Zealand (Two Degrees Mobile Limited, referred to below as "2degrees") and Bolivia (Empresa de Telecomunicaciones NuevaTel (PCS de Bolivia), S.A., referred to below as "NuevaTel"), is a provider of wireless voice and data communications services including local, international long distance and roaming services, for both subscribers and international visitors roaming on its networks. Trilogy LLC also provides fixed broadband communications services to residential and enterprise customers in New Zealand and Bolivia.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.63 out of 5 stars

Analyst Opinion: 3.5Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Trilogy International Partners (TSE:TRL) Frequently Asked Questions

Is Trilogy International Partners a buy right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Trilogy International Partners in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Trilogy International Partners stock.
View analyst ratings for Trilogy International Partners
or view top-rated stocks.

What stocks does MarketBeat like better than Trilogy International Partners?

Wall Street analysts have given Trilogy International Partners a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Trilogy International Partners wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Trilogy International Partners' next earnings date?

Trilogy International Partners is scheduled to release its next quarterly earnings announcement on Monday, June 21st 2021.
View our earnings forecast for Trilogy International Partners
.

How were Trilogy International Partners' earnings last quarter?

Trilogy International Partners Inc. (TSE:TRL) released its quarterly earnings results on Wednesday, March, 24th. The specialty pharmaceutical company reported ($0.27) EPS for the quarter. The specialty pharmaceutical company earned $220.01 million during the quarter.
View Trilogy International Partners' earnings history
.

How has Trilogy International Partners' stock been impacted by Coronavirus?

Trilogy International Partners' stock was trading at C$1.90 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, TRL stock has increased by 0.0% and is now trading at C$1.90.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for TRL?

2 brokers have issued twelve-month target prices for Trilogy International Partners' shares. Their forecasts range from C$2.00 to C$4.50. On average, they expect Trilogy International Partners' share price to reach C$3.00 in the next twelve months. This suggests a possible upside of 57.9% from the stock's current price.
View analysts' price targets for Trilogy International Partners
or view top-rated stocks among Wall Street analysts.

Who are Trilogy International Partners' key executives?

Trilogy International Partners' management team includes the following people:
  • Mr. John William Stanton B.A., M.B.A., BA, MBA, Co-Founder & Chairman (Age 66)
  • Mr. Bradley Jay Horwitz, Co-Founder, Pres, CEO & Non-Independent Director (Age 65, Pay $788.78k)
  • Ms. Theresa E. Gillespie, Co-Founder & Non-Independent Director (Age 68)
  • Mr. Erik Mickels CPA, Sr. VP & CFO
  • Mr. Scott Morris, Sr. VP, Gen. Counsel & Corp. Sec.
  • Mr. Tomas Perez, Chief Exec. Officer of NuevaTel
  • Mr. Mark Aue, Chief Exec. Officer of 2degrees
  • Ms. Ann Saxton, VP of Investor Relations & Corp. Devel.
  • Mr. Juan Pablo Calvo, Pres of Nuevatel

Who are some of Trilogy International Partners' key competitors?

What other stocks do shareholders of Trilogy International Partners own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Trilogy International Partners investors own include Acerus Pharmaceuticals (ASP), Emera (EMA), (MIICF), Merck & Co., Inc. (MRK), (ONCYF) (ONCYF), AxoGen (AXGN), A and W Revenue Royalties Income Fund (AW.UN), ATS Automation Tooling Systems (ATA), Algonquin Power & Utilities (AQN) and Apptio (APTI).

What is Trilogy International Partners' stock symbol?

Trilogy International Partners trades on the Toronto Stock Exchange (TSX) under the ticker symbol "TRL."

How do I buy shares of Trilogy International Partners?

Shares of TRL and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Trilogy International Partners' stock price today?

One share of TRL stock can currently be purchased for approximately C$1.90.

How much money does Trilogy International Partners make?

Trilogy International Partners has a market capitalization of C$113.85 million and generates C$626.85 million in revenue each year.

How many employees does Trilogy International Partners have?

Trilogy International Partners employs 1,663 workers across the globe.

What is Trilogy International Partners' official website?

The official website for Trilogy International Partners is www.trilogy-international.co....

Where are Trilogy International Partners' headquarters?

Trilogy International Partners is headquartered at Bellevue Wa PO Box 1988, BELLEVUE, WA 98009-1988, United States.

How can I contact Trilogy International Partners?

Trilogy International Partners' mailing address is Bellevue Wa PO Box 1988, BELLEVUE, WA 98009-1988, United States. The specialty pharmaceutical company can be reached via phone at +1-425-4585900.


This page was last updated on 6/20/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.